Healthcare is forever changed because of COVID-19. Terri Sanders of HIMSS and our Founder & CEO, Jim Weiss, share what innovations from the pandemic can shape the future of health.
The use of digital tools is not the same as digital transformation, so what does this mean for healthcare? Dr. Michael Blum, Chief Digital Transformation Officer of UCSF Health, joins the show to discuss the digital health renaissance, the progress needed for our industry, plus he shares a pretty clever answer for the album he'd bring on a desert island.
Telling stories of how information and tech can transform healthcare is essential for the entire ecosystem. Karen Groppe, Senior Director of Strategic Communications at HIMSS joins the show to discuss this, the importance of the whole message, and her love of Earth, Wind & Fire.
W2O recently acquired Swoop and IPM.ai to better equip our clients with tech-enabled solutions. This week, IPM.ai's Jonathan and W2O's Mary Claire Duch discuss our new partnership and the role tech-enablement plays in healthcare.
Empowering people with the right data to make healthy choices is the present and future of healthcare. Jeff Dachis, CEO & Founder of One Drop, discusses how the industry can make this happen and shares his appreciation of Led Zeppelin.
Colonoscopy Enthusiast & Colorectal Cancer Alliance Board Member, Brooks Bell, joins the show to share her colon cancer story. Plus, she discusses the importance of advocacy and ways we can all prevent, detect, and treat the third most common type of cancer.
Prioritizing mental health is important to your overall well-being, productivity, and happiness. Tiffany Shlain, Emmy-nominated Filmmaker, Author & Founder of The Webby Awards, shares the power of giving up screens one day a week.
The importance of data and statistics in the healthcare industry cannot be overstated. Sara Hughes, SVP & Head of Biostatistics at GSK joins the show to discuss the role of data in health, and shares how leveraging statistics can create a healthier world.
Jane Sarasohn-Kahn, Author, Health Economist & Advisor, rejoins the show and her message about health citizenship could not be timelier. She unpacks the 2020 Election, key trends, COVID-19, and what this all potentially means for healthcare.
Earlier this week we announced starpower is a part of the W2O team! W2O Global President, Jennifer Gottlieb, chats with starpower Founders and Managing Partners, Matt Lalin and Jared Weiss, to discuss why we made our long-standing partnership official, the power of influencer marketing, and how we will continue to be first at what's next in healthcare.
Hemant Taneja, Investor, Entrepreneur, and Author joins the show to discuss the importance of health assurance, shares why tech shouldn't disrupt health and reminisces over Bob Marley.
Redesigning conventional drug development to function efficiently during COVID-19 and other pandemics is essential. Professor Gareth Griffiths and Professor Saye Khoo explain how their platform, AGILE, is designed to do this necessary work.
Guy D’Andrea, Founder & Managing Partner of Discern Health (a W2O company), outlines the fundamentals of value-based healthcare, he discusses Discern and W2O's recent partnership and shares his love of U2.
On June 2nd 2019, Miles Hall was in a mental crisis. When his family called law enforcement for help, he was shot and killed by the Walnut Creek Police. Taun Hall, Miles' mother and Co-Founder of the Miles Hall Foundation, shares his story.
Physicians treating patients from marginalized communities must practice cultural humility. Dr. Monica Gandhi, SF Co-Chair for the AIDS 2020 Conference, discusses this on our latest episode of What2Know. She also shares lessons from the HIV pandemic that apply to the COVID-19 pandemic, and she discusses this year's AIDS 2020 Conference.
Health equity is at the forefront of the COVID-19 conversation. Cynthia Carey-Grant, Oakland Co-Chair for the AIDS 2020 Conference joins the show to discuss health disparities within marginalized communities. She also shares the parallels between HIV and the coronavirus and highlights what she's looking forward to during this year's virtual conference.
Jennifer Gottlieb, W2O Global President, and Muscular Dystrophy Association (MDA) Board Member chats with Lynn O'Connor Vos, President & CEO of the MDA. The two discuss how the MDA has pivoted amid COVID-19 and how the MDA is transforming the lives of people with neuromuscular diseases.
Creating cultural competency within healthcare organizations is key for patients. Eloiza Domingo of Astellas Pharma US discusses the importance of cultural competency within the industry and unpacks how diversity and inclusion improves patient outcomes.
Dr. Sir Michael Jacobs, Infectious Diseases Physician & Clinical Director of Infection at the Royal Free Hospital outlines what is being learned about COVID-19 and how these learnings impact treatment.
W2O recently acquired Symplur to strengthen and scale data for smarter healthcare decision making. Our own Adam Cossman, Audun Utengen, and Seth Duncan discuss what this looks like for our clients, how we've partnered to combat COVID-19 and the power of social data within the industry.
During COVID-19, it's essential for organizations to communicate effectively to their key stakeholders, particularly their employees. Ellen Gerstein, Head of Content & Employee Advocacy at Pfizer, and Managing Director of W2O, Wendy Carhart, discuss best practices for organizations to follow.
There are actions our leaders and society can take to combat the coronavirus. Dilawar Syed, President & CEO of Lumiata, discusses steps to fight COVID-19, he shares the role government is playing, plus he unpacks how AI can be part of the solution.
Dr. Angela Rasmussen, Associate Research Scientist at Columbia University Mailman School of Public Health, discusses misconceptions around the corona virus, the importance of investment in public health, and what we all can do about COVID 19.
We took a short break, but we’re back! This week, Rob Butcher, President & CEO of Swim Across America joins the show. He shares the importance of funding cancer research, discusses how his organization raises money to support research, plus he gives two solid book recommendations.
Conducting clinical trials properly is essential for participation. Ken Getz, Deputy Director & Research Professor at Tufts Center for the Study of Drug Development, discusses how to design clinical trials well and he shares how technology has changed the industry.